Roflumilast – A Potential New First Line Systemic Drug for Psoriasis.
Dr. Zachariae reviews the potential of using Roflumilast as an oral treatment for psoriasis. Watch Video
The Global Psoriasis Atlas in Greenland - May 2022.
The Global Psoriasis Atlas (GPA) is a joint project of the ILDS (International League of Dermatological Societies),… Read More